Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Silymarin for Improving Hepatitis C
NCT01292161Phase 2Completed
- Start
- Mar 2006
- Primary completion
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of silymarin in hepatitis C (HCV). Started Mar 2006; status: completed.
02
Drugs
silymarin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT01292161.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01292161.